Showing results (11-20 of 150) with videos related to
Sort By:
Pageof 15
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 1, 1994
Cost effectiveness in the management of benign prostatic hyperplasia: Italian dataF Di Silverio, G D'Eramo, G P Flammia, et al.Steroids|June 10, 1998
Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgensS Monti, F Di Silverio, S Lanzara, et al.British Journal of Urology|November 1, 1992
Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in ItalyF Di SilverioEuropean Urology|January 1, 1992
Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patientsF Di Silverio, G D'Eramo, C Lubrano, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptorsC Lubrano, F Sciarra, G Spera, et al.Journal of Steroid Biochemistry|January 1, 1989
Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasiaC Lubrano, E Petrangeli, A Catizone, et al.The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1993
Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasiaC Lubrano, V Toscano, E Petrangeli, et al.Journal of Andrology|July 20, 2000
Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaPL Ravenna, L Salvatori, S Morrone, et al.The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgensS Monti, F Di Silverio, R Iraci, et al.Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|March 1, 1997
Safety profile of selective alpha-1 adrenoceptor antagonists in the treatment of benign prostatic hyperplasiaA Sciarra, F Di SilverioPageof 15